Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Researchers at Novartis present new insulin-like growth factor 1 receptor antagonists

Jan. 18, 2012

Full results published of phase III breast cancer study CLEOPATRA

Jan. 18, 2012

Phase III study of elacytarabine delayed by manufacturing issues

Jan. 17, 2012

Novel insulin-like growth factor 1 receptor antagonists patented by Novartis

Jan. 17, 2012

Novel dual specificity protein kinase TTK inhibitors reported

Jan. 16, 2012

Polaris begins dosing in ADI-PEG 20/docetaxel combination study

Jan. 13, 2012

NovoMedix patents new eIF4E inhibitors for cancer

Jan. 13, 2012

Evotec achieves milestone for oncology product from Boehringer Ingelheim

Jan. 13, 2012

Novartis discovers new pan-Trk kinase inhibitor

Jan. 13, 2012

Kadmon acquires anticancer candidate from Concordia Pharmaceuticals

Jan. 12, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...